Keen Eye Technologies
AI platform elevates pathology for drug development and diagnostics, supporting all stages and organ classes.
General Information
Get notified when Keen Eye Technologies moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Keen Eye Technologies
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
About Keen Eye Technologies
Taxonomy: AI platform, computational pathology, drug development, diagnostics, preclinical phase, clinical assay development, tissue analysis, organ class analysis, therapeutic area analysis
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 1 |
|
29 Apr 2019 |
| Seed Round | •••••• | 1 |
|
12 Dec 2016 |
Keen Eye Technologies Alternatives & Competitors
Experts in Sterile Drug Product Development Services
-logo.jpg "New England Discovery Partners (NEDP)"){kind=logo}
Making molecules that matter
Specialists in orally inhaled and nasal drug product (OINDP) development and analytics
FAQ About Keen Eye Technologies
Don't just browse. Track.
Signal Tracker monitors Keen Eye Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.